Medical Conference: The Impact of Environment and Healthy Lifestyles in Human Health
The medical conference is organized by the Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation Guest speakers include Roberto Lucchini, Giuseppe Loianno, Giacomina Massaro-Giordano, Giovan Giacomo Giordano. Special guest, Ms. Nathalie Dompé, CEO Dompé Holdings The conference takes place on October 13th in Washington, D.C.
Newswise — The Sbarro Health Research Organization (SHRO), in collaboration with Temple University’s College of Science and Technology, the National Italian American Foundation (NIAF), and the Giovan Giacomo Giordano Foundation will host the medical conference “The Impact of Environment and Healthy Lifestyles in Human Health” 9 AM on Saturday, October 13th at the Marriot Wardman Park Hotel in Washington, D.C.
The conference will feature introductions presented by SHRO’s President, Antonio Giordano, who also serves as Director of the Sbarro Institute for Cancer Research and Molecular Medicine and Center for Biotechnology and by Temple University Vice President for Research, Michele Masucci, PhD., Temple and CST are leaders in biotech research and development, and recently launched Masters’ programs in both Bioinnovation and Biotechnology.
Guest speakers include Roberto Lucchini, M.D., Giuseppe Loianno, Ph.D., and Giacomina Massaro-Giordano, M.D. Dr. Lucchini, of the University of Brescia, will address “Impacts of Environmental Hazards on Human Health: From the 9/11 Dust to the Industrial Emissions of Taranto, Puglia.” Dr. Loianno will discuss “Drones for Health: Agricultural and Infrastructure Monitoring.” And Dr. Massaro-Giordano will report on “Dompé: FDA Approval of the First Medicine Based on Human Nerve Growth Factor: An Italian Pharma Success Story.” Dr. Massaro was the principle investigator for the study at the University of Pennsylvania, Scheie Eye Institute. This site was instrumental in enrolling the most patients in the U.S. to demonstrate Oxervate’s efficacy in treating NK, and in enrolling a significant number of patients from a separate trial, which helped establish the safety of the product. These achievements were essential for the FDA approval of Oxervate. A special recognition will be given to Nathalie Dompé for her work and effort promoting social responsibility and with the visually impaired.
The conference will culminate in the presentation of the 2016 Giovan Giacomo Giordano NIAF Lifetime Achievement Award for Ethics and Creativity in Medical Research by Mrs. Dolores Del Raso and Dr. Giacomina Massaro - Giordano. This award was established six year ago in honor of Dr. Giordano’s father, the late Professor Giovan Giacomo Giordano, renowned pathologist and former chair of the Department of Pathology, Second University of Naples, who dedicated more than sixty years of his life to the study of cancer and the role of environmental factors in the onset of this disease. Professor Giovan Giacomo Giordano was also a major advocate against corruption in the Italian medical community and driving force for the establishment of medical ethical standards amongst his colleagues.
Special guest, Ms. Nathalie Dompé, CEO Dompé Holdings, Vice President, Business Development at Dompé Pharmaceuticals responsible for the oversight, market development and strategic approval of all new programs launched by the Company in the United States, will receive the Special Award for Societal Impact in Business & Biotechnology.